Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

Share Price is delayed by 15 minutes
Get Live Data
685.50    -7.50 (-1.08%)
Bid:
687.50
Ask:
689.00
Spread: 1.50 (0.218%)
Market Cap: £1.17b
BOY Live PriceLast checked at - London Stock Exchange

Intraday Bodycote Share Chart

Divisional re-statement for enhanced Optimise programme

18 Nov 2025 07:05

Bodycote Plc - Divisional re-statement for enhanced Optimise programme

Bodycote Plc - Divisional re-statement for enhanced Optimise programme

PR Newswire

LONDON, United Kingdom, November 18

18 November 2025

Bodycote plc

Divisional re-statement for enhanced Optimise programme

Β 

Β 

Bodycote, the world's leading provider of specialist thermal processing services, today publishes historical financial information for 2024 and the first half of 2025 reflecting a new divisional reporting structure.

Β 

At our Half Year results on 30 July 2025 we announced an expansion to the scope of our ongoing Optimise programme. The revised and final programme, which includes 30 plants, will deliver an improved run-rate profit benefit of at least Β£15m by mid-2027 for a net cash cost of Β£10-15m. As a result of this expanded scope, the additional plants will now be classified as Non-Core. Our Full Year 2025 results will be presented based on this updated structure.

Β 

The tables below show our H1 2024, FY 2024 and H1 2025 divisional performance on the new re-classified basis. The historical financial information contained in the following tables is unaudited.

Β 

Β 

Half year to 30 June 2025

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

Β£m

Β£m

Β£m

Β£m

Β£m

Β£m

Revenue

104.5

232.1

-

336.6

32.4

369.0

Adjusted operating profit/(loss)

27.2

34.9

(8.6)

53.5

1.6

55.1

Return on sales

26.0%

15.0%

Β 

15.9%

4.9%

14.9%

Β 

Β 

Β 

Half year to 30 June 2024

Β 

Β 

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

Β£m

Β£m

Β£m

Β£m

Β£m

Β£m

Revenue

115.3

243.0

-

358.3

40.7

399.0

Adjusted operating profit/(loss)

34.4

40.4

(10.2)

64.6

2.2

66.8

Return on sales

29.8%

16.6%

Β 

18.0%

5.4%

16.7%

Β 

Β 

Β 

2024 FY

Β 

Β 

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

Β£m

Β£m

Β£m

Β£m

Β£m

Β£m

Revenue

222.3

459.8

-

682.1

75.0

757.1

Adjusted operating profit/(loss)

65.5

80.4

(20.4)

125.5

3.5

129.0

Return on sales

29.5%

17.5%

Β 

18.4%

4.7%

17.0%

Β 

Β 

Β 

Β 

Β 

Β 

For further information, please contact:

Β 

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Investor Relations and FP&A

Tel: +44 1625 505 300

Β 

Disclosures:

This announcement contains forward-looking statements based on current expectations and assumptions. Various known and unknown risks, uncertainties and other factors may cause actual results to differ from future results or developments expressed or implied from the forward-looking statements. Each forward-looking statement speaks only as of the date of this document. Bodycote plc accepts no obligation to revise or update these forward-looking statements publicly or adjust them to future events or developments, whether as a result of new information, future events or otherwise, except to the extent legally required.

Β 



Date   Source Headline
25th May 20222:41 pmPRNDirector/PDMR Shareholding
25th May 202212:21 pmRNSResult of AGM
25th May 20227:11 amRNSAudit Committee Chair Succession
25th May 20227:00 amRNSTrading Update
13th Apr 202211:00 amPRNHolding(s) in Company
6th Apr 20229:07 amPRNDirector/PDMR Shareholding
4th Apr 20224:16 pmPRNFinal Dividend Payment Date
31st Mar 20225:02 pmPRNTotal Voting Rights
28th Mar 202212:13 pmPRNDirector/PDMR Shareholding
25th Mar 20223:18 pmPRNDirector/PDMR Shareholding
25th Mar 20221:39 pmPRNAnnual Financial Report
25th Mar 20221:12 pmPRNDirector/PDMR Shareholding
15th Mar 20224:53 pmPRNDirector/PDMR Shareholding
14th Mar 20227:00 amRNSFull year results for year ended 31 December 2021
11th Mar 20227:00 amRNSAppointment of Non-Executive Director
8th Mar 20227:46 amPRNHolding(s) in Company
28th Feb 20225:01 pmPRNTotal Voting Rights
7th Feb 20227:00 amRNSDirectorate Change
4th Feb 20228:51 amPRNHolding(s) in Company
4th Feb 20228:48 amPRNHolding(s) in Company
31st Jan 20225:00 pmPRNTotal Voting Rights
31st Dec 20211:30 pmPRNTotal Voting Rights
20th Dec 20217:00 amRNSDirectorate Change
30th Nov 20215:03 pmPRNTotal Voting Rights
23rd Nov 20217:00 amRNSTrading Update
22nd Nov 20218:53 amPRNHolding(s) in Company
29th Oct 20215:05 pmPRNTotal Voting Rights
8th Oct 202110:17 amPRNHolding(s) in Company
4th Oct 20213:31 pmPRNHolding(s) in Company
30th Sep 20215:30 pmPRNTotal Voting Rights
21st Sep 20219:41 amPRNHolding(s) in Company
16th Sep 20219:34 amPRNHolding(s) in Company
14th Sep 20212:43 pmRNSHolding(s) in Company
14th Sep 202112:09 pmRNSHolding(s) in Company
7th Sep 20213:51 pmPRNHolding(s) in Company
3rd Sep 20214:10 pmPRNHolding(s) in Company
31st Aug 20215:02 pmPRNTotal Voting Rights
20th Aug 20214:26 pmRNSHolding(s) in Company
17th Aug 20214:05 pmRNSHolding(s) in Company
30th Jul 20215:03 pmPRNTotal Voting Rights
30th Jul 20217:57 amPRNHolding(s) in Company
29th Jul 20217:00 amRNSInterim results for the six months to 30 June 2021
2nd Jul 20214:30 pmPRNHolding(s) in Company
30th Jun 20215:05 pmPRNTotal Voting Rights
9th Jun 20211:42 pmPRNHolding(s) in Company
28th May 20215:02 pmPRNTotal Voting Rights
27th May 20215:09 pmRNSDirectorate Change
27th May 202112:39 pmRNSResult of AGM
27th May 20217:00 amRNSTrading Update
17th May 20215:00 pmPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.